Loeb Partners Corp’s Precigen PGEN Stock Holding History

Loeb Partners Corp’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150	Closed	-$1K	–	99
2019 Q1	$1K	Hold	150	–	–	0.02%	128
2018 Q4	$1K	Buy	+150	New	+$1.68K	﹤0.01%	294

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loeb Partners Corp's PGEN Position: Q2 2019 in Review

Loeb Partners Corp sold out of Precigen (PGEN) in Q2 2019, closing a stake of 150 shares — an estimated $1K sold.

Loeb Partners Corp first reported a position in PGEN in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 162 funds tracked by Wall St. Rank hold PGEN as of Q2 2019.

Loeb Partners Corp reported no remaining Precigen position as of Q2 2019 after selling out during the quarter.
Loeb Partners Corp sold 150 Precigen shares in Q2 2019, an estimated $1K.
Loeb Partners Corp first reported a position in Precigen in Q4 2018 and held it in 2 quarters.
Loeb Partners Corp's Precigen position peaked at $1K in Q1 2019.
162 funds tracked by Wall St. Rank held Precigen as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.